Left ventricular myocardial perfusion and function in systemic sclerosis before and after diltiazem treatment

Scandinavian Journal of Rheumatology

Volumn 25, Issue 5, 1996, Pages 317-320

  Geirsson, A J ^a   Danielsen, R ^a   Petursson E ^a  

^a LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

Author keywords

Function; Myocardium; Perfusion; Systemic sclerosis

Indexed keywords

DILTIAZEM; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE PERFUSION; HEART SCINTISCANNING; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS;

EID: 0029961821     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.3109/03009749609104064     Document Type: Article

References (22)

1. Campell PM, LeRoy EC. Pathogenesis of systemic sclerosis: a vascular hypothesis. Semin Arthritis Rheum 1975; 4: 351-68.
2. Fries JF. The microvascular pathogenesis of scleroderma: an hypothesis. Ann Intern Med 1979; 91: 788-9.
3. Belch JJF. Raynaud's phenomenon, its relevance to scleroderma. Ann Rheum Dis 1991; 50: 839-45.
4. Follansbee WP, Curtiss EI, Medsger TA, et al. Physiologic abnormalities of cardiac function in progressive systemic sclerosis with diffuse scleroderma. N Engl J Med 1984; 310: 142-8.
5. Long A, Duffy G, Breshnian B. Reversible myocardial perfusion defects during cold challenge in scleroderma. Br J Rheumatol 1986; 25: 158-61.
6. Alexander EL, Fierstein GS, Weiss JL, et al. Reversible cold-induced abnormalities in myocardial perfusion and function in systemic sclerosis. Ann Intern Med 1986; 105: 661-8.
7. Kahan A, Devaux JY, Amor B, et al. Nifedipine and thallium-201 myocardial perfusion in progressive systemic sclerosis. N Engl J Med 1986; 314: 1397-402.
8. D'Angelo WA, Fries JA, Masi AT, Schulman LE. Pathologic observation in systemic sclerosis (scleroderma): a study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med 1969; 46: 428-40.
9. Bulkley BH, Ridolfi RL, Salyer WR, Hutchins GM. Myocardial lesions of progressive systemic sclerosis: a cause of cardiac dysfunction. Circulation 1976; 53: 483-90.
10. Ferri C, Bernini L, Bongiorni MG, et al. Noninvasive evaluation of cardiac dysrhythmias and their relationship with multisystemic symptoms, in progressive systemic sclerosis patients. Arthritis Rheum 1985; 28: 1259-66.
11. Geirsson AJ, Blom-Bülow B, Pahlm O, Åkeson A. Cardiac involvement in systemic sclerosis. Semin Arthritis Rheum 1989; 19: 110-6.
12. Botstein GR, LeRoy CE, Primary heart disease in systemic sclerosis (scleroderma): Advances in clinical and pathological features, pathogenesis, and new therapeutic approches. Am Heart J 1981; 102: 913-9.
13. Reichenbach DD, Benditt EP. Myofibrillar degeneration-a responce of the myocardial cell to injury. Arch Pathol Lab Med 1968; 85: 189.
14. Follansbee WP, Zerbe TR, Medsger TA. Cardiac and skeletal muscle disease in systemic sclerosis (scleroderma): A high risk association. Am Heart J 1993; 125: 194-203.
15. Maione S, Valentini G, Giunta A, et al. Evaluation of cardiac structures and function in systemic sclerosis by doppler echocardiography. Cardiology 1991; 79: 165-71.
16. Kazzam E, Caidahl K, HS̀llgren R, et al. Non-invasive assessment of systolic function in systemic sclerosis. Eur Heart J 1991; 12: 151-6.
17. Hegedüs I, Czirák L. Left ventricular wall thickness and disease duration in systemic sclerosis. Postgrad Med J 1993; 69: 285-90.
18. Kazzam E, Waldenström A, Landelius J, et al. Non-invasive assessment of left ventricular diastolic function in patients with systemic sclerosis. J Intern Med 1990; 228: 183-92.
19. Kahan A, Devaux JY, Amor B, et al. Nicardipine improves myocardial perfusion in systemic sclerosis. J Rheumatol 1988; 15: 1395-400.
20. Kahan A, Devaux JY, Amor B, et al. Pharmacodynamic effect of nicardipine on left ventricular function in systemic sclerosis. J Cardiovasc Pharmacol 1990; 15: 249-53.
21. Duboc D, Kahan A, Maziere B, et al. The effect of nifedipine on myocardial perfusion and metabolism in systemic sclerosis. Arthritis Rheum 1991; 34: 198-203.
22. Kazzam E, Caidahl K, Hällgren R, Gustafsson R, Waldenström A. Non-invasive evaluation of long-term effects of captopril in systemic sclerosis. J Intern Med 1991; 230: 203-12.